Alveolar Soft Part Sarcoma

Search Trials
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer
Status:
Terminated
Last Changed:
Jul 2, 2015
First Changed:
May 28, 2010
Disease(s):
Cancer
Intervention(s):
cyproheptadine hydrochlorideplacebo
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
Status:
Active, not recruiting
Last Changed:
May 25, 2022
First Changed:
Aug 16, 2016
Disease(s):
Adrenal Cortex Carcinoma
Intervention(s):
Cabozantinib S-malateLaboratory Biomarker AnalysisPharmacological Study
Axitinib and Pembrolizumab in Subjects With Advanced Alveolar Soft Part Sarcoma and Other Soft Tissue Sarcomas
Status:
Active, not recruiting
Last Changed:
Nov 26, 2021
First Changed:
Dec 22, 2015
Disease(s):
Alveolar Soft Part Sarcoma
Intervention(s):
AxitinibPembrolizumabBlood DrawTumor Specimen Collection
CREATE: Cross-tumoral Phase 2 With Crizotinib
Status:
Active, not recruiting
Last Changed:
May 10, 2022
First Changed:
Feb 2, 2012
Disease(s):
Locally Advanced and/or Metastatic Anaplastic Large Cell Lymphoma
Intervention(s):
Crizotinib (PF-02341066)
Trial of Dasatinib in Advanced Sarcomas
Status:
Completed
Last Changed:
Nov 23, 2018
First Changed:
Apr 23, 2007
Disease(s):
Rhabdomyosarcoma
Intervention(s):
Dasatinib

Connect. Empower. Inspire.